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Summary and Implications
The effect of dietary additions of Echinacea purpurea
on the rate of rate of growth, viremia, and ontogeny of the
humoral antibody response against porcine reproductive and
respiratory syndrome virus (PRRSV) infection was
evaluated in  weaned pigs. In three replicates, weaned pigs
(18 ± 1 day of age) from a PRRSV-naïve herd were
randomly allotted to one of four pens (diets) in two rooms,
each pen containing five pigs. Each pen of pigs (pens) began
one of four dietary treatments 1 week before inoculation
with PRRSV: 1) basal ration plus carbadox (0.055 g/kg); 2)
basal ration plus Echinacea I (2% of the total ration); 3)
basal ration plus Echinacea II (4% of the total ration); and 4)
basal ration composed of corn, soybean meal, whey, and
supplemented essential vitamins and minerals. E. purpurea
was purchased in powder form and determined by chemical
analysis to contain 1.35% cichoric acid. Seven days after
starting the diets (day 7), all pigs in one room were
intranasally inoculated with PRRSV isolate ATCC VR-2332
at a concentration of 104 TCID50/ml. To monitor the effects
of diet and PRRSV infection, body weight and blood
samples were collected from all pigs at 7-day intervals (day
0 to 42). Serum samples were analyzed for the presence of
PRRSV and PRRSV-specific antibodies. All inoculated pigs
become infected with PRRSV and all uninoculated pigs
remained free of infection. PRRSV-infected pigs had a
lower percentage increase in body weight between day 7
and 42 compared with uninfected animals (P<0.06). There
were no differences in body weight, average daily gain
(ADG), average daily feed intake (ADFI), or gain:feed ratio
(G:F) in PRRSV-infected compared with uninfected
animals. Animals receiving diets supplemented with
Echinacea (treatments 2 and 3), no differences were
observed in percentage increase in body weight, ADG,
ADFI, and G:F ratio in either the PRRSV-infected and the
uninfected pigs. Among PRRSV-infected animals, dietary
Echinacea did not affect the rate or level of the ELISA-
detectable antibody response day 7 to 42 or the level and
duration of PRRSV in serum. Under the conditions of this
study, dietary Echinacea did not reverse the growth-
inhibiting effects of PRRSV, did not exhibit antiviral effects
and did not show any evidence of immunostimulatory
properties.
Introduction
Antimicrobial agents are given to food animals as
therapy for an infection or, in the absence of disease, for the
subtherapeutic purpose of increased rate of gain and
improved feed efficiency (1, 2). Increasing interest to curb
the use of antibiotics has led to a growing interest in
alternatives. Botanicals may be used in swine diets because
of their natural stimulation of the immune system and/or
enhanced growth performance. Extracts from Echinacea
have been shown to have nonspecific immunostimulatory
properties in vitro (3). Nonspecific effects include
phagocytosis (4), cytokine production (5), and natural killer
cell activity (6). Rehman et al. (7) showed an increase in
primary and secondary IgG response in mice treated with
Echinacea. These antiviral properties of Echinacea could
provide resistance to viral swine diseases, such as PRRSV
and diminish opportunistic secondary infections. Few
scientific studies have assessed the efficacy of Echinacea in
vivo with varying results (8–10). We know of no studies
involving pigs as an animal model in assessing the efficacy
of Echinacea as an immunostimulant. Work with Echinacea
as a possible growth promotant is limited (11). Therefore,
our objectives were to determine the effects of E. purpurea




Three replicate trials involving a total of 120 pigs
(average initial body weight of 8.46 kg) were conducted at
the Iowa State University Livestock Infectious Disease
Isolation Facility (LIDIF), Ames, IA.  All pigs were
farrowed and reared at the Iowa State University Lauren
Christian Swine Research and Demonstration Farm,
Atlantic, IA. The protocol was approved by the Iowa State
University Committee on Animal Care (Log No. 6-1-4861-
S). In each trial, 40 crossbred piglets from a herd naïve for
PRRSV were weaned between 17 to 19 days of age and
allotted to one of eight pens in two separate rooms (four
pens per room). Pigs were allotted to balance for pig weight
and litter origin. At birth, the pigs were tail docked, ear
notched, teeth clipped, males castrated, and injected
subcutaneously with 2 ml of iron dextran and 0.5 ml of
ceftiofur sodium). On day 7, all pigs received a second
injection of 1 ml of ceftiofur sodium. At weaning (day 17 to
19), all pigs received injections of 0.5 ml of ivermectin and
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1 ml of penicillin, were weighed, allotted, and moved to
their treatment. Two pigs were removed before inoculation.
Feed disappearance, body weights, and blood were collected
at 7-day intervals until the completion of each 42-day trial.
The ADG, ADFI, G:F, and percentage gain were calculated.
The blood samples were centrifuged at 2000 × g for 10 min
at 4°C. The serum was stored at –20°C until tested.
Housing
LIDIF is a biosafety level 2 building. The environment
in each room is strictly controlled  (humidity 70%,
temperature 26.6˚C). The pigs were housed in an infected
room or a control (uninfected) room. Five pigs were allotted
per pen on nursery decks (1.22 × 2.43 m) with plastic slatted
floor. Each pen had one nipple waterer and a 4-hole Kane
polyethylene nursery feeder.
Experimental diets
Four dietary treatments were fed (one per pen) in each
room during each trial. The diets were identical except for
the treatment additives containing carbadox (0.055 g/kg),
Echinacea I (2% of total ration), Echinacea II (4% of total
ration), and control (no additive). Four phases of each diet
were fed to coincide with stages of growth to meet or
exceed nutritional requirements (12). All diets were in meal
form and animals were given ad libitum access to feed.
The gross energy of Echinacea was determined to be
3344 kcal/kg (adiabatic bomb calorimeter; Parr Instrument
Company Inc., Moline, IL). Using the gross energy value of
Echinacea and values from the NRC (12) and Ewan (13),
the diets were adjusted to compensate for the low energy
value of Echinacea. The diets were formulated to be
isolysinic. Feeding mats (0.42 × 0.77 m) were placed in
front of the feeders. Waste feed was minimal and not
recorded.
Certified organic E. purpurea root was used for the
presumed immunostimulatory activity of the caffeic acid
derivative, cichoric acid (14). Three-year-old plants were
harvested in September and the root was dried with forced
air to a moisture content of 9% (Nature’s Cathedral Inc.,
Blairstown, IA). The root was ground and sifted to a powder
then mixed with basal diets and fed. The treatment levels of
2 and 4% Echinacea were chosen based on preliminary
work at Iowa State University (11). Determination of
phenolics in Echinacea was performed by Alpha
Laboratories Division (Petaluma, CA). High-pressure liquid
chromatography was used to determine the content of
caftaric acid, chlorogenic acid, cichoric acid, and
echinacoside in the dried powdered E. purpurea root. The
final results are expressed as a percentage of the total
components in the material analyzed. The Echinacea
contained 0.39% caftaric acid, 0.01% chlorogenic acid, less
than 0.01% echinacoside, and 1.35% cichoric acid.
Virus preparation
A clone of North American prototype PRRSV isolate
ATCC VR-2332 (15, 16) was used in the study. The
concentration of 104 TCID50/ml of the cloned virus was
adjusted for the challenge virus. Pigs exposed to PRRSV
were intranasally inoculated on day 7 with 2 ml (1 ml/naris)
of clarified virus supernatant.
Enzyme-linked immunosorbent assay
A commercial ELISA kit (Herdchek Porcine
Reproductive and Respiratory Syndrome Virus Antibody
kit, IDEXX Laboratories, Westbrook, ME) was used to
detect PRRSV-specific antibody in serum samples. A
sample was classified as positive for PRRSV antibody if the
sample-to-positive (S/P) ratio was equal to or greater than
0.4.
Data analysis
Data were analyzed as a complete randomized block
design by analysis of variance techniques using general
linear model (GLM) of SAS (SAS Inc., Cary, NC). The pig
was considered the experimental unit for absolute weights,
ADG, PRRSV-specific antibodies, and serum virus
concentrations. The pen was used as the experimental unit
for ADFI and G:F ratio. Pig weight at day 0 was used as a
covariate when analyzing pig performance. Data were
reported as least-square means.
Results and Discussion
Growth
Feeding Echinacea to PRRSV-infected pigs had no
effect on individual pig body weight, percentage gain, ADG,
ADFI, or G:F ratio compared with carbadox and control
treatments (Table 2). Feeding Echinacea to PRRSV
uninfected pigs had no effect on individual pig body weight,
percentage gain, ADG, ADFI, or G:F ratio compared with
carbadox and control treatments (Table 3).
PRRSV-infected pigs had a lower percentage increase
in body weight between day 7 and 42 compared with
uninfected animals (P<0.06) (Table 4). No differences were
seen between PRRSV-infected compared with uninfected
animals in body weight, ADG, ADFI, or G:F. According to
these data, PRRSV inhibited growth of infected animals
compared with healthy animals over time.
Viremia
E. purpurea was fed before inoculation with PRRSV
until the end of the 42-day trial to ensure possible antiviral
and immunostimulatory properties time to be observed. E.
purpurea has been shown to increase IgG levels and reduce
virus titer in rats (7). However, in the current study feeding
dietary Echinacea to the PRRSV-infected pigs did not
stimulate an ELISA-detectable antibody response (Table 5).
Dietary Echinacea did not affect the level or duration of
viremia. Specifically animals fed diets supplemented with
Echinacea were the lasts to reach a zero serum PRRSV titer
(Table 6). No differences were detected for the dietary
treatments in number of pigs positive for PRRSV antibody
or from which virus was recovered from serum (Tables 7
and 8). Based on this study, E. purpurea is not an effective
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alternative as a growth promotant in nursery pigs. E.
purpurea with this defined chemical profile did not
stimulate antigen specific antibodies to PRRSV, inhibit
virus replication, or improve elimination of virus from
nursery pigs. Continued work is needed to establish the
chemical constituents of E. purpurea that exhibit antiviral
and immunostimulatory properties and their mechanisms in
pigs.
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Table 1. Basal diet composition (as-fed basis).
Ingredient Phase 1 Phase 2
% Diet
Phase 3 Phase 4
Corn 36.65 48.20 62.55 67.45
Dehulled soybean
meal
29.00 37.00 32.50 28.00
Dried whey 25.00 10.00 0 0
Dicalcium phosphate 1.45 2.0 1.7 1.45
Fat 1.0 1.0 1.0 1.0
Calcium carbonate .90 .70 .90 .90
Vitamin premix .60a .50b .45c .45c
Lysine .20 .20 .20 .10
Mineral premixd .10 .10 .10 .10
D,L-Methionine .10 .10 .10 .10
Salt 0 .20 .50 .45
Spray dried plasma 5.0 0 0 0
Total 100 100 100 100
Calculated Analysis
CP, % 24.2 23.0 20.7 18.9
Lysine, % 1.71 1.50 1.31 1.10
ME, kcal/kg 3264 3269 3291 3304
a
 Contributed per kilogram of diet: 13,200 IU of vitamin A; 3,300 IU of vitamin D3; 66 IU of vitamin E; 19.8 g of
riboflavin; 52 mg of d-pantothenic acid; 100 mg of niacin; 60 µg of vitamin B12.
b
 Contributed per kilogram of diet: 11,000 IU of vitamin A; 2,750 IU of vitamin D3; 55 IU of vitamin E; 16.5 g of
riboflavin; 43.3 mg of d-pantothenic acid; 83.3 mg of niacin; 55 µg of vitamin B12.
c
 Contributed per kilogram of diet: 9,900 IU of vitamin A; 2,475 IU of vitamin D3; 49.5 IU of vitamin E; 14.9 g of
riboflavin; 39 mg of d-pantothenic acid; 75 mg of niacin; 49.5 µg of vitamin B12.
d
 Contributed in part per million of diet: Zn, 150.0; Fe, 175.0; Mn, 60.0; Cu, 17.6; and I, 2.0.
Table 2. Effects of feeding E. purpurea on growth performance in nursery pigs infected with PRRSV.
Dietary treatment
Item Carbadox Control Echinacea I Echinacea II SEM
Total ADG, kg 489 513 528 522 0.02
Total ADFI, g 850 810 843 879 0.04
Total G:F, g/kg 634 719 696 641 0.08
ADG, average daily growth; ADFI, average daily feed intake.
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Table 3. Effects of feeding E. purpurea on growth performance in nursery pigs.
Dietary treatment
Item Carbadox Control Echinacea I Echinacea II SEM
Total ADG, g 524 525 527 547 0.02
Total ADFI, g 910 824 861 884 0.04
Total G:F, g/kg 632 824 674 667 0.08
ADG, average daily growth; ADFI, average daily feed intake.
Table 4. Analysis of summary for growth data for PRRSV infected and uninfected pigs.a,b
TreatmentDay of experiment
PRRSV Negative PRRSV Positive SEM
0–42 270.8 261.5 6.5
7–42 211.3c 199.2d 4.5
21–42 84.5 82.8 1.8
aValues are least-square means of the percent gain of individual pigs.
bInoculation with PRRS virus at day 7 of the trial.
c,dMean values within rows with a different superscript differ (P<0.06).
Table 5. Enzyme-linked immunosorbent assay serum-to-positive ratios for PRRSV-infected pigs.a,b
TreatmentDay of experiment
Carbadox Control Echinacea I Echinacea II SEM
0 0.00 0.02 0.01 0.00 0.006
7 0.00 0.00 0.00 0.01 0.004
14 0.01 0.04 0.02 0.02 0.008
21 0.67 0.79 0.46 0.47 0.157
28 1.03 1.06 0.78 0.71 0.122
35 1.47 1.49 1.25 1.19 0.109
42 1.49 1.44 1.29 1.39 0.114
aValues are least-square means of the serum-to-positive ratios for individual pig samples.
bInoculation with PRRS virus at day 7.
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Table 6. Serum PRRSV titer for PRRSV-infected pigs.a,b
TreatmentDay of experiment
Carbadox Control Echinacea I Echinacea II SEM
14 3.11 2.85 2.50 2.50 0.33
21 2.15 2.24 2.20 2.18 0.26
28 0.97 0.88 0.80 1.11 0.26
d 35 0.05 0.00 0.39 0.29 0.14
d 42 0.00 0.02 0.17 0.02 0.06
aValues are least square means of the log10 (TCID50/mL) for individual pig samples.
bInoculation with PRRS virus at day 7.
Table 7. Number of pigs within treatment groups positive for PRRSV antibody.a
Dietary treatmentbDay of experiment
Carbadox Control Echinacea I Echinacea II
0 0 0 0 0
7 0 0 0 0
14 0 0 0 0
21 10 9 6 6
28 15 14 11 10
35 15 15 15 14
42 15 15 15 15
an=15 pigs for each dietary treatment.
bInoculation with PRRS virus at day 7.
Table 8. Number of pigs within treatment groups from which PRRSV was recovered from serum
samples.a,b
Dietary treatmentDay of experiment
Carbadox Control Echinacea I Echinacea II
14 15 14 11 11
21 14 14 14 12
28 11 1 6 9
35 2 0 3 3
42 0 1 2 1
an = 15 pigs for each dietary treatment.
bInoculation with PRRS virus at day 7.
